Your browser doesn't support javascript.
loading
Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity.
Gandhi, Shipra; Pandey, Manu R; Attwood, Kristopher; Ji, Wenyan; Witkiewicz, Agnieszka K; Knudsen, Erik S; Allen, Cheryl; Tario, Joseph D; Wallace, Paul K; Cedeno, Carlos D; Levis, Maria; Stack, Suzanne; Funchain, Pauline; Drabick, Joseph J; Bucsek, Mark J; Puzanov, Igor; Mohammadpour, Hemn; Repasky, Elizabeth A; Ernstoff, Marc S.
Afiliação
  • Gandhi S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York. shipra.gandhi@roswellpark.org.
  • Pandey MR; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Attwood K; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Ji W; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Witkiewicz AK; Center for Personalized Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Knudsen ES; Center for Personalized Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Allen C; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Tario JD; Department of Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Wallace PK; Department of Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Cedeno CD; Department of Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Levis M; Clinical Research Service, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Stack S; Clinical Research Service, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Funchain P; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio.
  • Drabick JJ; Division of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania.
  • Bucsek MJ; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Mohammadpour H; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Repasky EA; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Ernstoff MS; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Clin Cancer Res ; 27(1): 87-95, 2021 01 01.
Article em En | MEDLINE | ID: mdl-33127652
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Propranolol / Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Melanoma Tipo de estudo: Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Propranolol / Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Melanoma Tipo de estudo: Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article